Title:
A COMBINATION FORMULATION COMPRISING HMG-COA REDUCTASE INHIBITOR AND CALCIUM CHANNEL BLOCKER
Document Type and Number:
WIPO Patent Application WO/2018/199636
Kind Code:
A1
Abstract:
The present invention relates to an oral combination formulation comprising a first composition comprising amlodipine or a pharmaceutically acceptable salt thereof, a disintegrant, and a sugar alcohol; and a second composition comprising rosuvastatin or a pharmaceutically acceptable salt thereof, and a stabilizer, and a preparation method thereof.
Inventors:
LEE SI BEUM (KR)
HA SONG YI (KR)
HONG HYE SUK (KR)
LEE YOON JUNG (KR)
HA SONG YI (KR)
HONG HYE SUK (KR)
LEE YOON JUNG (KR)
Application Number:
PCT/KR2018/004815
Publication Date:
November 01, 2018
Filing Date:
April 25, 2018
Export Citation:
Assignee:
ALVOGEN KOREA CO LTD (KR)
International Classes:
A61K9/20; A61K9/28; A61K31/4422; A61K31/505
Domestic Patent References:
| WO2006070248A1 | 2006-07-06 |
Foreign References:
| KR20170007695A | 2017-01-19 | |||
| KR20150067777A | 2015-06-19 | |||
| US20110130416A1 | 2011-06-02 | |||
| US20150098992A1 | 2015-04-09 |
Attorney, Agent or Firm:
SON, Min (KR)
Download PDF: